(Q50909597)

English

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.

scientific article published on 15 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Susan Costantini

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Giuseppe Castello

14

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

15

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

object named as

Serena Zanotta

9

0 references

Francesca Capone

object named as

Francesca Capone

6

0 references

Maria Napolitano

object named as

Maria Napolitano

2

0 references

object named as

Sandro Pignata

13

0 references

11

object named as

Nicola Longo

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

author name string

Marianeve Polimeno

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Luigi Portella

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Arianna Esposito

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Eliana Guerriero

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Annamaria Trotta

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Luigi Pucci

10

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

Sisto Perdonà

12

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

publication date

15 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

112

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

686-696

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

The role of T-regulatory cells in pregnancy and cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

FOXP3+ regulatory T cells in the human immune system

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

MetPA: a web-based metabolomics tool for pathway analysis and visualization

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

A survey of current software for network analysis in molecular biology

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Targeted therapies in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

The blockade of IL-6 signaling in rational drug design

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Interleukin-6 signaling pathway in targeted therapy for cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12068

21 January 2018

Identifiers

10.1111/BJU.12068

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23495770

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50909597&oldid=2146222516"